ANI Pharmaceuticals Q1 revenue rose 43.4% to $197.12 million, EPS beat consensus, and 2025 guidance was raised on strong ...

We recently published a list of 10 Best Cancer Stocks to Invest in for Long-Term Gains. In this article, we are going to take ...

Analysts expect HighPeak Energy to report an earnings per share (EPS) of $0.34. Anticipation surrounds HighPeak Energy's announcement, with investors hoping to hear about both surpassing estimates and ...

Puma Biotechnology PBYI reported first-quarter 2025 adjusted earnings of 10 cents per share, which beat the Zacks Consensus Estimate of 2 cents. In the year-ago quarter, the company had incurred a ...

Birthday deals in metro Phoenix include free meals, free admission to attractions and even free ice cream on your big day.

CRISPR Therapeutics benefits from Casgevy’s approval and a deep pipeline, despite early rollout hurdles and cost challenges.

One reason investors should be cautious, outside of the unprecedented level of uncertainty created by U.S. tariff policy, is ...

Pizza Pizza’s royalty structure and 10% return potential make it attractive for income investors, even with limited payout ...

Gold Royalty Corp (GROY) reports record operating cash flow and outlines strategic growth initiatives, despite facing production setbacks and market undervaluation.

"Franco-Nevada is reporting its best financial results ever," stated Paul Brink, CEO. "We achieved record quarterly top and bottom-line results, absent any contributions from Cobre Panama. Results ...